| Year |
Citation |
Score |
| 2017 |
Conery AR, Centore RC, Spillane KL, Follmer NE, Bommi-Reddy A, Hatton C, Bryant BM, Greninger P, Amzallag A, Benes CH, Mertz JA, Sims RJ. Abstract B19: Targeting dependencies within apoptotic pathways through inhibition of BET bromodomains Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-B19 |
0.323 |
|
| 2016 |
Conery AR, Centore RC, Spillane KL, Follmer NE, Bommi-Reddy A, Hatton C, Bryant BM, Greninger P, Amzallag A, Benes CH, Mertz JA, Sims RJ. Preclinical anticancer efficacy of BET bromodomain inhibitors is determined by the apoptotic response. Cancer Research. PMID 26759243 DOI: 10.1158/0008-5472.Can-15-1458 |
0.303 |
|
| 2015 |
Centore RC, Hatton C, Bryant B, Sims RJ. Abstract B21: Identifying mechanisms of resistance to BET bromodomain inhibition. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-B21 |
0.308 |
|
| 2015 |
Conery AR, Centore RC, Hatton C, Neiss A, Huang H, Keller PJ, Taylor AM, Cote A, Hewitt MC, Nasveschuk CG, Leblanc Y, Yao S, Pardo E, Zawadzke L, Poy F, et al. Abstract A20: A leukemic model of acquired resistance to BET inhibition reveals a role for CBP/EP300 bromodomains in the regulation of c-MYC expression Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A20 |
0.31 |
|
| 2012 |
Centore RC, Yazinski SA, Tse A, Zou L. Spartan/C1orf124, a reader of PCNA ubiquitylation and a regulator of UV-induced DNA damage response. Molecular Cell. 46: 625-35. PMID 22681887 DOI: 10.1016/J.Molcel.2012.05.020 |
0.659 |
|
| 2012 |
Havens CG, Shobnam N, Guarino E, Centore RC, Zou L, Kearsey SE, Walter JC. Direct role for proliferating cell nuclear antigen in substrate recognition by the E3 ubiquitin ligase CRL4Cdt2. The Journal of Biological Chemistry. 287: 11410-21. PMID 22303007 DOI: 10.1074/Jbc.M111.337683 |
0.398 |
|
| 2011 |
Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, Chang S, Karlseder J, Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature. 471: 532-6. PMID 21399625 DOI: 10.1038/Nature09772 |
0.543 |
|
| 2010 |
Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A, Jin J, Dyson NJ, Walter JC, Zou L. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Molecular Cell. 40: 22-33. PMID 20932472 DOI: 10.1016/J.Molcel.2010.09.015 |
0.504 |
|
| 2009 |
Centore RC, Leeson MC, Sandler SJ. UvrD303, a hyperhelicase mutant that antagonizes RecA-dependent SOS expression by a mechanism that depends on its C terminus. Journal of Bacteriology. 191: 1429-38. PMID 19074381 DOI: 10.1128/Jb.01415-08 |
0.687 |
|
| 2008 |
Long JE, Renzette N, Centore RC, Sandler SJ. Differential requirements of two recA mutants for constitutive SOS expression in Escherichia coli K-12. Plos One. 3: e4100. PMID 19116657 DOI: 10.1371/Journal.Pone.0004100 |
0.687 |
|
| 2008 |
Centore RC, Lestini R, Sandler SJ. XthA (Exonuclease III) regulates loading of RecA onto DNA substrates in log phase Escherichia coli cells. Molecular Microbiology. 67: 88-101. PMID 18034795 DOI: 10.1111/J.1365-2958.2007.06026.X |
0.75 |
|
| 2007 |
Centore RC, Sandler SJ. UvrD limits the number and intensities of RecA-green fluorescent protein structures in Escherichia coli K-12. Journal of Bacteriology. 189: 2915-20. PMID 17259317 DOI: 10.1128/Jb.01777-06 |
0.78 |
|
| 2005 |
Renzette N, Gumlaw N, Nordman JT, Krieger M, Yeh SP, Long E, Centore R, Boonsombat R, Sandler SJ. Localization of RecA in Escherichia coli K-12 using RecA-GFP. Molecular Microbiology. 57: 1074-85. PMID 16091045 DOI: 10.1111/J.1365-2958.2005.04755.X |
0.55 |
|
| Show low-probability matches. |